As a negative feedback response to the interferon γ (IFNγ) released by T lymphocytes at the tumor site, IDO-1 is activated and degrades tryptophan, further inducing T lymphocytes’ proliferation arrest and ­apoptosis by triggering an adaptive evasion from the immune control72,76. Here, IDO1 is linked to neoplasm.